Hangzhou Tigermed Consulting : POLL VOTING RESULTS OF THE 2021 SECOND EXTRAORDINARY GENERAL MEETING HELD ON MARCH 26, 2021

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

HANGZHOU TIGERMED CONSULTING CO., LTD.

؄ψइࣸᔼᖹ߅Ҧٰ΅Ϟࠢʮ̡

(A joint stock company incorporated in the People's Republic of China with limited liability)

(Stock Code: 3347)

POLL VOTING RESULTS OF THE 2021 SECOND EXTRAORDINARY

GENERAL MEETING HELD ON MARCH 26, 2021

The board of directors (the "Board") of Hangzhou Tigermed Consulting Co., Ltd. (the "Company") is pleased to announce that the 2021 second extraordinary general meeting (the "EGM") of the Company was duly convened on March 26, 2021 and the resolution proposed at the EGM was duly passed by the shareholders of the Company (the "Shareholders") by way of poll.

Reference is made to the circular of the Company dated March 11, 2021 (the "Circular"), which set out the resolution to be considered by the Shareholders. Unless otherwise indicated, the capitalised terms used in this announcement shall have the same meaning as those defined in the Circular.

The Board is pleased to announce that the EGM was held at 19/F, Building 8, No. 19 Jugong Road, Binjiang District, Hangzhou, the PRC, on Friday, March 26, 2021 at 3 p.m. The chairman of the Board, Mr. Ye Xiaoping, is unable to chair the EGM due to work arrangements, and more than half of the Directors have elected Ms. Cao Xiaochun, a Director, to chair such meeting. In accordance with relevant PRC laws and regulations, the holders of A Shares were entitled to attend the EGM and vote in person, by proxy, or via network for the relevant resolution. The time of network voting for the resolution proposed at the EGM for holders of A Shares on March 26, 2021 was set out in the notice of the EGM to holders of A Shares published on the website of Shenzhen Stock Exchange separately.

VOTE TAKING AND WITNESS LAWYERS

Poll voting for the resolution of the EGM was taken in accordance with Rule 13.39(4) of the Listing Rules and the Articles of Association. Two representatives of the Shareholders, Mr. Wu Baolin, a supervisor of the Company, and the representative from Jia Yuan Law Offices, the PRC legal advisor of the Company, acted as the joint scrutineers in respect of the voting at the EGM, while Tricor Investor Services Limited, the Company's H Share registrar, acted as the scrutineer in respect of the EGM and performed the calculation to obtain the poll voting results with respect to the H Shares.

Jia Yuan Law Offices confirmed that, the convening, holding, attendants, qualification of convener and voting procedures of the EGM conformed to the Company Law of the PRC, the Securities Law of the PRC, the Rules of Procedures of Shareholders' General Meeting of Listed Companies and other relevant laws and regulations as well as the Articles of Association. The EGM was legal and valid.

RESULTS OF THE EGM

The total number of shares entitling the Shareholders to attend the EGM is 872,483,508 Shares (including 749,358,708 A Shares and 123,124,800 H Shares), being the total number of shares entitling the Shareholders to vote on the resolution proposed at the EGM. The Shareholders, holding in aggregate 472,938,652 Shares, representing approximately 54.21% of the total number of shares carrying the voting rights on the resolution, attended the EGM and voted in respect of the resolution proposed at the EGM in person, by proxy or via network. Among which, 395,234,681 shares were held by the holders of A Shares, representing approximately 45.30% of the total number of shares carrying the voting rights, 77,703,971 shares were held by the holders of H Shares, representing approximately 8.91% of the total number of shares carrying the voting rights.

So far as the Directors are aware, having made all reasonable inquiries, no Shareholders was required to abstain from voting on any resolution proposed at the EGM under the Listing Rules. No Shareholder who was entitled to attend had to abstain from voting in favour of any resolution at the EGM pursuant to Rule 13.40 of the Listing Rules. No Shareholders indicated their intention in the Circular to vote against or abstain from voting in respect of any resolution proposed at the EGM.

Please refer to the Circular for full text of the resolution. The poll results in respect of the resolution at the EGM are as follows:

ORDINARY RESOLUTION

Number of Shares

1

To consider and approveA Shares the proposed adoption of the Subsidiary ShareOption Scheme

331,683,011

H Shares

Total

51,692,266383,375,277

For
Percentage	Number	Percentage	Number	Percentage
(%)	of Shares	(%)	of Shares	(%)
63,551,670	16.0795%	0	0.0000%
26,011,705	33.4754%	0	0.0000%
89,563,375	18.9376%	0	0.0000%

Against

Abstain

83.9205%

66.5246% 81.0624%As more than half of the votes were cast in favor of this resolution, the resolution was duly passed as an ordinary resolution.

By order of the Board

Hangzhou Tigermed Consulting Co., Ltd.

Ye Xiaoping

Chairman

Hong Kong, March 26, 2021

As at the date of this announcement, the executive Directors of the Company are Dr. Ye Xiaoping, Ms. Cao Xiaochun and Ms. Yin Zhuan; the independent non-executive Directors are Mr. Zheng Bijun, Dr. Yang Bo and Mr. Liu Kai Yu Kenneth.